When was LABORATOIRES FILL-MED MANUFACTURING founded?

LABORATOIRES FILL-MED MANUFACTURING was founded on 18 Dec 2012, making it 13 years old.

Is LABORATOIRES FILL-MED MANUFACTURING still active?

Yes, LABORATOIRES FILL-MED MANUFACTURING is currently active.

Where is LABORATOIRES FILL-MED MANUFACTURING registered?

LABORATOIRES FILL-MED MANUFACTURING's registered address is Boulevard Paepsem 18, 1070 Anderlecht, Belgium.

How many employees does LABORATOIRES FILL-MED MANUFACTURING have?

Based on its most recently filed annual accounts (fiscal year ending 31 Dec 2025), LABORATOIRES FILL-MED MANUFACTURING reported 36 full-time equivalent employees.

What is LABORATOIRES FILL-MED MANUFACTURING's annual turnover?

LABORATOIRES FILL-MED MANUFACTURING's most recently filed annual turnover (fiscal year ending 31 Dec 2025) was €17,133,060.

Did LABORATOIRES FILL-MED MANUFACTURING make a profit or a loss?

LABORATOIRES FILL-MED MANUFACTURING's most recently filed annual accounts (fiscal year ending 31 Dec 2025) reported a profit of €1,252,395.

When did LABORATOIRES FILL-MED MANUFACTURING last file annual accounts?

LABORATOIRES FILL-MED MANUFACTURING's most recently filed annual accounts cover the fiscal year ending 31 Dec 2025.

Is LABORATOIRES FILL-MED MANUFACTURING B Corp certified?

We have no B Corp certification on file for LABORATOIRES FILL-MED MANUFACTURING.

Does LABORATOIRES FILL-MED MANUFACTURING hold Fairtrade certification?

No, LABORATOIRES FILL-MED MANUFACTURING does not currently hold Fairtrade certification.

LABORATOIRES FILL-MED MANUFACTURING

Q: What does LABORATOIRES FILL-MED MANUFACTURING do?

LABORATOIRES FILL-MED MANUFACTURING's registered main activities are Wholesale of pharmaceutical and medical goods, Research and experimental development on other natural sciences and engineering, Activities of agents involved in non-specialised wholesale, Manufacture of basic pharmaceutical products, Manufacture of beauty and make-up products, Wholesale trade of hygiene products, Wholesale of perfume and cosmetics, Leasing of intellectual property and similar products, except copyrighted works, Commission trade of perfumes, cosmetics, toiletries and cleaning products, Manufacture of homogenised food preparations and dietetic food, and Activities of holding companies.

BE 0508.506.959

Copied!

NV/SA

Status

Active

Founded

18 Dec 2012

Size

Medium · 36 FTE

Age

13 yrs

Main activity

Wholesale of pharmaceutical and medical goods

Activities

11 activities

Wholesale of pharmaceutical and medical goodsResearch and experimental development on other natural sciences and engineeringActivities of agents involved in non-specialised wholesaleManufacture of basic pharmaceutical productsManufacture of beauty and make-up productsWholesale trade of hygiene productsWholesale of perfume and cosmeticsLeasing of intellectual property and similar products, except copyrighted worksCommission trade of perfumes, cosmetics, toiletries and cleaning productsManufacture of homogenised food preparations and dietetic foodActivities of holding companies

Financials

Turnover2025

€17.1M-27%

Profit / Loss2025

€1.3M-45.5%

Equity2025

€5.8M-11.7%

2025	2024	2023	2022
€17,133,060-27%	€23,461,952-7.4%	€25,325,541-31.8%	€37,139,492
€1,252,395-45.5%	€2,298,091-46.4%	€4,284,654-65.2%	€12,296,437
€5,779,784-11.7%	€6,543,804-9.9%	€7,262,127-9.1%	€7,993,887
€18,567,262-11.8%	€21,042,160-16.1%	€25,067,023-21.4%	€31,892,536
€315,815-72.7%	€1,158,331+436.5%	€215,899+29.1%	€167,185
36+2.3%	35.2-3.6%	36.5+19.7%	30.5
€475,918-28.6%	€666,533-3.9%	€693,850-43%	€1,217,688

Frequently asked questions

01What is LABORATOIRES FILL-MED MANUFACTURING's official registered name?

LABORATOIRES FILL-MED MANUFACTURING.

02What is LABORATOIRES FILL-MED MANUFACTURING's enterprise number (VAT number)?

BE 0508.506.959.

03What is LABORATOIRES FILL-MED MANUFACTURING's legal form?

Naamloze vennootschap (NV) / Société anonyme (SA).

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

Financial statements

	2025	2024	2023	2022
Income statement
	€17,133,060-27%	€23,461,952-7.4%	€25,325,541-31.8%	€37,139,492
	36+2.3%	35.2-3.6%	36.5+19.7%	30.5
	€475,918-28.6%	€666,533-3.9%	€693,850-43%	€1,217,688
	€2,982,108+10.7%	€2,693,329+0.7%	€2,676,033+20.4%	€2,221,916
	€1,706,165-43.8%	€3,035,978-45.3%	€5,547,422-66.4%	€16,517,478
	€2,466,448-34.7%	€3,777,736-38.1%	€6,102,789-64.3%	€17,093,880
	€699,103-83.9%	€4,353,424	—	—
	€1,252,395-45.5%	€2,298,091-46.4%	€4,284,654-65.2%	€12,296,437
	€103,028+25.7%	€81,947-34.8%	€125,680-84.5%	€810,308
Profitability
	14.4%-10.6%	16.1%-33.2%	24.1%-47.6%	46.0%
	7.3%-25.4%	9.8%-42.1%	16.9%-48.9%	33.1%
	21.7%-38.3%	35.1%-40.5%	59.0%-61.6%	153.8%
	5.1%-35.3%	8.0%-40%	13.3%-57%	30.8%
Solvency
	€24,347,047-15.7%	€28,899,537-10.6%	€32,329,149-18.9%	€39,886,423
	€13,406,890+16.8%	€11,481,973+53.9%	€7,459,462+124.3%	€3,326,390
	€12,720+220.8%	€3,965+97.7%	€2,0050%	€2,005
	€5,779,784-11.7%	€6,543,804-9.9%	€7,262,127-9.1%	€7,993,887
	23.7%+4.8%	22.6%+0.8%	22.5%+12.1%	20.0%
	€18,567,262-11.8%	€21,042,160-16.1%	€25,067,023-21.4%	€31,892,536
	3.21-0.1%	3.22-6.8%	3.45-13.5%	3.99
	—	—	—	407.84
Liquidity
	€315,815-72.7%	€1,158,331+436.5%	€215,899+29.1%	€167,185
	€4,359,706-33.1%	€6,519,496-39.6%	€10,788,672+88.5%	€5,722,208
	€4,494,678-27.9%	€6,231,711+6.3%	€5,863,100-75.8%	€24,264,535
	€12,743,683-25.8%	€17,176,111-10.3%	€19,158,372-6%	€20,386,200
	€18,498,561-11.5%	€20,893,541-16.2%	€24,933,145-21.2%	€31,627,693
	0.53-21.7%	0.68-11.9%	0.77-25.5%	1.04
	-€8,369,307-49.9%	-€5,584,262-1.4%	-€5,509,176-525.9%	€1,293,423
Efficiency
	96 days-1.2%	97 days+14.7%	85 days-64.6%	238 days
	342 days-23.1%	445 days+17.1%	380 days-2.8%	391 days
	269 days-37.2%	428 days-31.4%	624 days+97%	317 days
	1.09+70.3%	0.64-15.8%	0.76-51.9%	1.58
Profit appropriation
	€2,000,000-33.3%	€3,000,000-40%	€5,000,000-50%	€10,000,000
	€6,1500%	€6,1500%	€6,1500%	€6,150
	€5,704,676-11.6%	€6,452,281-9.8%	€7,154,190-9.1%	€7,869,536

Sources

NBB — Nationale Bank van België

	2025	2024	2023	2022
Income statement
	€17,133,060-27%	€23,461,952-7.4%	€25,325,541-31.8%	€37,139,492
	36+2.3%	35.2-3.6%	36.5+19.7%	30.5
	€475,918-28.6%	€666,533-3.9%	€693,850-43%	€1,217,688
	€2,982,108+10.7%	€2,693,329+0.7%	€2,676,033+20.4%	€2,221,916
	€1,706,165-43.8%	€3,035,978-45.3%	€5,547,422-66.4%	€16,517,478
	€2,466,448-34.7%	€3,777,736-38.1%	€6,102,789-64.3%	€17,093,880
	€699,103-83.9%	€4,353,424	—	—
	€1,252,395-45.5%	€2,298,091-46.4%	€4,284,654-65.2%	€12,296,437
	€103,028+25.7%	€81,947-34.8%	€125,680-84.5%	€810,308
Profitability
	14.4%-10.6%	16.1%-33.2%	24.1%-47.6%	46.0%
	7.3%-25.4%	9.8%-42.1%	16.9%-48.9%	33.1%
	21.7%-38.3%	35.1%-40.5%	59.0%-61.6%	153.8%
	5.1%-35.3%	8.0%-40%	13.3%-57%	30.8%
Solvency
	€24,347,047-15.7%	€28,899,537-10.6%	€32,329,149-18.9%	€39,886,423
	€13,406,890+16.8%	€11,481,973+53.9%	€7,459,462+124.3%	€3,326,390
	€12,720+220.8%	€3,965+97.7%	€2,0050%	€2,005
	€5,779,784-11.7%	€6,543,804-9.9%	€7,262,127-9.1%	€7,993,887
	23.7%+4.8%	22.6%+0.8%	22.5%+12.1%	20.0%
	€18,567,262-11.8%	€21,042,160-16.1%	€25,067,023-21.4%	€31,892,536
	3.21-0.1%	3.22-6.8%	3.45-13.5%	3.99
	—	—	—	407.84
Liquidity
	€315,815-72.7%	€1,158,331+436.5%	€215,899+29.1%	€167,185
	€4,359,706-33.1%	€6,519,496-39.6%	€10,788,672+88.5%	€5,722,208
	€4,494,678-27.9%	€6,231,711+6.3%	€5,863,100-75.8%	€24,264,535
	€12,743,683-25.8%	€17,176,111-10.3%	€19,158,372-6%	€20,386,200
	€18,498,561-11.5%	€20,893,541-16.2%	€24,933,145-21.2%	€31,627,693
	0.53-21.7%	0.68-11.9%	0.77-25.5%	1.04
	-€8,369,307-49.9%	-€5,584,262-1.4%	-€5,509,176-525.9%	€1,293,423
Efficiency
	96 days-1.2%	97 days+14.7%	85 days-64.6%	238 days
	342 days-23.1%	445 days+17.1%	380 days-2.8%	391 days
	269 days-37.2%	428 days-31.4%	624 days+97%	317 days
	1.09+70.3%	0.64-15.8%	0.76-51.9%	1.58
Profit appropriation
	€2,000,000-33.3%	€3,000,000-40%	€5,000,000-50%	€10,000,000
	€6,1500%	€6,1500%	€6,1500%	€6,150
	€5,704,676-11.6%	€6,452,281-9.8%	€7,154,190-9.1%	€7,869,536

2025

2024

2023

2022

Income statement

€17,133,060-27%

€23,461,952-7.4%

€25,325,541-31.8%

€37,139,492

36+2.3%

35.2-3.6%

36.5+19.7%

30.5

€475,918-28.6%

€666,533-3.9%

€693,850-43%

€1,217,688

€2,982,108+10.7%

€2,693,329+0.7%

€2,676,033+20.4%

€2,221,916

€1,706,165-43.8%

€3,035,978-45.3%

€5,547,422-66.4%

€16,517,478

€2,466,448-34.7%

€3,777,736-38.1%

€6,102,789-64.3%

€17,093,880

€699,103-83.9%

€4,353,424

—

€1,252,395-45.5%

€2,298,091-46.4%

€4,284,654-65.2%

€12,296,437

€103,028+25.7%

€81,947-34.8%

€125,680-84.5%

€810,308

Profitability

14.4%-10.6%

16.1%-33.2%

24.1%-47.6%

46.0%

7.3%-25.4%

9.8%-42.1%

16.9%-48.9%

33.1%

21.7%-38.3%

35.1%-40.5%

59.0%-61.6%

153.8%

5.1%-35.3%

8.0%-40%

13.3%-57%

30.8%

Solvency

€24,347,047-15.7%

€28,899,537-10.6%

€32,329,149-18.9%

€39,886,423

€13,406,890+16.8%

€11,481,973+53.9%

€7,459,462+124.3%

€3,326,390

€12,720+220.8%

€3,965+97.7%

€2,0050%

€2,005

€5,779,784-11.7%

€6,543,804-9.9%

€7,262,127-9.1%

€7,993,887

23.7%+4.8%

22.6%+0.8%

22.5%+12.1%

20.0%

€18,567,262-11.8%

€21,042,160-16.1%

€25,067,023-21.4%

€31,892,536

3.21-0.1%

3.22-6.8%

3.45-13.5%

3.99

—

407.84

Liquidity

€315,815-72.7%

€1,158,331+436.5%

€215,899+29.1%

€167,185

€4,359,706-33.1%

€6,519,496-39.6%

€10,788,672+88.5%

€5,722,208

€4,494,678-27.9%

€6,231,711+6.3%

€5,863,100-75.8%

€24,264,535

€12,743,683-25.8%

€17,176,111-10.3%

€19,158,372-6%

€20,386,200

€18,498,561-11.5%

€20,893,541-16.2%

€24,933,145-21.2%

€31,627,693

0.53-21.7%

0.68-11.9%

0.77-25.5%

1.04

-€8,369,307-49.9%

-€5,584,262-1.4%

-€5,509,176-525.9%

€1,293,423

Efficiency

96 days-1.2%

97 days+14.7%

85 days-64.6%

238 days

342 days-23.1%

445 days+17.1%

380 days-2.8%

391 days

269 days-37.2%

428 days-31.4%

624 days+97%

317 days

1.09+70.3%

0.64-15.8%

0.76-51.9%

1.58

Profit appropriation

€2,000,000-33.3%

€3,000,000-40%

€5,000,000-50%

€10,000,000

€6,1500%

€6,150

€5,704,676-11.6%

€6,452,281-9.8%

€7,154,190-9.1%

€7,869,536

LABORATOIRES FILL-MED MANUFACTURING

Activities

Financials

Frequently asked questions

All locations

Financial statements

All locations

Financial statements